BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29616035)

  • 1. A Framework for Understanding the Evasion of Host Immunity by
    Garcia-Perez JE; Mathé L; Humblet-Baron S; Braem A; Lagrou K; Van Dijck P; Liston A
    Front Immunol; 2018; 9():538. PubMed ID: 29616035
    [No Abstract]   [Full Text] [Related]  

  • 2. Deciphering mechanisms of staphylococcal biofilm evasion of host immunity.
    Hanke ML; Kielian T
    Front Cell Infect Microbiol; 2012; 2():62. PubMed ID: 22919653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida albicans biofilm development on medically-relevant foreign bodies in a mouse subcutaneous model followed by bioluminescence imaging.
    Kucharíková S; Vande Velde G; Himmelreich U; Van Dijck P
    J Vis Exp; 2015 Jan; (95):52239. PubMed ID: 25651138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Virtual Infection Modeling of Fungal Immune Evasion in Human Whole Blood.
    Prauße MTE; Lehnert T; Timme S; Hünniger K; Leonhardt I; Kurzai O; Figge MT
    Front Immunol; 2018; 9():560. PubMed ID: 29619027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing.
    Xie Z; Thompson A; Sobue T; Kashleva H; Xu H; Vasilakos J; Dongari-Bagtzoglou A
    J Infect Dis; 2012 Dec; 206(12):1936-45. PubMed ID: 23033146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida albicans biofilms: antifungal resistance, immune evasion, and emerging therapeutic strategies.
    Fan F; Liu Y; Liu Y; Lv R; Sun W; Ding W; Cai Y; Li W; Liu X; Qu W
    Int J Antimicrob Agents; 2022; 60(5-6):106673. PubMed ID: 36103915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host contributions to construction of three device-associated Candida albicans biofilms.
    Nett JE; Zarnowski R; Cabezas-Olcoz J; Brooks EG; Bernhardt J; Marchillo K; Mosher DF; Andes DR
    Infect Immun; 2015 Dec; 83(12):4630-8. PubMed ID: 26371129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host responses to Candida albicans. A review.
    Zdanavičienė E; Sakalauskienė J; Gleiznys A; Gleiznys D; Žilinskas J
    Stomatologija; 2017; 19(4):109-123. PubMed ID: 29806649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida albicans biofilms: development, regulation, and molecular mechanisms.
    Gulati M; Nobile CJ
    Microbes Infect; 2016 May; 18(5):310-21. PubMed ID: 26806384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans.
    Luo S; Skerka C; Kurzai O; Zipfel PF
    Mol Immunol; 2013 Dec; 56(3):161-9. PubMed ID: 23809232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida-Bacterial Biofilms and Host-Microbe Interactions in Oral Diseases.
    Negrini TC; Koo H; Arthur RA
    Adv Exp Med Biol; 2019; 1197():119-141. PubMed ID: 31732939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine model for the evaluation of candiduria caused by Candida tropicalis from biofilm.
    Capote-Bonato F; Bonato DV; Ayer IM; Magalhães LF; Magalhães GM; Pereira da Câmara Barros FF; Teixeira PPM; Crivellenti LZ; Negri M; Svidzinski TIE
    Microb Pathog; 2018 Apr; 117():170-174. PubMed ID: 29471135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungal immune evasion in a model host-pathogen interaction: Candida albicans versus macrophages.
    Jiménez-López C; Lorenz MC
    PLoS Pathog; 2013; 9(11):e1003741. PubMed ID: 24278014
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of interferon-γ and granulocyte colony-stimulating factor on antifungal activity of human polymorphonuclear neutrophils against Candida albicans grown as biofilms or planktonic cells.
    Katragkou A; Simitsopoulou M; Chatzimoschou A; Georgiadou E; Walsh TJ; Roilides E
    Cytokine; 2011 Sep; 55(3):330-4. PubMed ID: 21641233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection.
    Fujimoto K; Takemoto K
    J Infect Chemother; 2018 Dec; 24(12):958-964. PubMed ID: 30209024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines.
    Chandra J; McCormick TS; Imamura Y; Mukherjee PK; Ghannoum MA
    Infect Immun; 2007 May; 75(5):2612-20. PubMed ID: 17339351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.
    Höfs S; Mogavero S; Hube B
    J Microbiol; 2016 Mar; 54(3):149-69. PubMed ID: 26920876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mnn10 Maintains Pathogenicity in Candida albicans by Extending α-1,6-Mannose Backbone to Evade Host Dectin-1 Mediated Antifungal Immunity.
    Zhang SQ; Zou Z; Shen H; Shen SS; Miao Q; Huang X; Liu W; Li LP; Chen SM; Yan L; Zhang JD; Zhao JJ; Xu GT; An MM; Jiang YY
    PLoS Pathog; 2016 May; 12(5):e1005617. PubMed ID: 27144456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioluminescence imaging increases in vivo screening efficiency for antifungal activity against device-associated Candida albicans biofilms.
    Vande Velde G; Kucharíková S; Van Dijck P; Himmelreich U
    Int J Antimicrob Agents; 2018 Jul; 52(1):42-51. PubMed ID: 29572043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida albicans Biofilms and Human Disease.
    Nobile CJ; Johnson AD
    Annu Rev Microbiol; 2015; 69():71-92. PubMed ID: 26488273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.